Anbio Biotechnology (NNNN)

Anbio Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Apr 25, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	287	-	-	-
Enterprise Value	276	-	-	-
Asset Turnover	0.55	0.45	2.50	-
Quick Ratio	28.28	11.65	6.14	2.06
Current Ratio	35.56	15.86	9.88	2.07
Return on Equity (ROE)	26.64%	16.47%	132.75%	-
Return on Assets (ROA)	15.05%	8.23%	67.52%	-
Return on Capital (ROIC)	15.92%	8.96%	84.50%	-
Return on Capital Employed (ROCE)	22.50%	13.20%	81.30%	96.80%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q